Science & Research

Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.

Discover the science behind Rapamycin and how it impacts the aging process, and PEARL, the first human clinical study for Rapamycin.